To investigate whether serum ITGB6 could be used for tumor surveillance and monitoring of tumor recurrence during the follow-up of gastric cancer patients, we detected the expression of serum ITGB6 before and after surgery, and followed up the patients for 6 months in the prospective cohort. This evidence concerns the gene ITGB6 and neoplasm.